Symbols / HSTM Stock $25.24 -0.20% HealthStream, Inc.

Healthcare • Health Information Services • United States • NMS
HSTM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Robert A. Frist Jr.
Exch · Country NMS · United States
Market Cap 737.39M
Enterprise Value 684.96M
Income 19.92M
Sales 311.78M
FCF (ttm) 49.80M
Book/sh 12.01
Cash/sh 2.28
Employees 1,139
Insider 10d —
IPO Apr 11, 2000
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 19.10%
P/E 37.67
Forward P/E 29.18
PEG 2.95
P/S 2.37
P/B 2.10
P/C —
EV/EBITDA 16.29
EV/Sales 2.20
Quick Ratio 0.81
Current Ratio 0.97
Debt/Eq 4.00
LT Debt/Eq —
EPS (ttm) 0.67
EPS next Y 0.86
EPS Growth 42.90%
Revenue Growth 10.50%
EPS Gr Q/Q 36.40%
Rev Gr Q/Q —
Earnings (next) 2026-08-03
Earnings (prior) 2026-05-04
ROA 2.84%
ROE 5.57%
ROIC —
Gross Margin 64.89%
Oper. Margin 9.25%
Profit Margin 6.39%
Shs Outstand 29.22M
Shs Float 23.21M
Insider Own 20.39%
Instit Own 75.63%
Short Float 5.67%
Short Ratio 4.51
Short Interest 1.11M
52W High 29.63
vs 52W High -14.82%
52W Low 19.50
vs 52W Low 29.44%
Beta 0.47
Impl. Vol. 52.93%
Rel Volume 0.67
Avg Volume 274.00K
Volume 183.48K
Target (mean) $32.00
Tgt Median $32.00
Tgt Low $24.00
Tgt High $40.00
# Analysts 2
Recom None
Prev Close $25.29
Price $25.24
Change -0.20%
About

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system. It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$32.00
Mean price target
2. Current target
$25.24
Latest analyst target
3. DCF / Fair value
$30.69
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$25.24
Low
$24.00
High
$40.00
Mean
$32.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-06 main Canaccord Genuity Hold → Hold $24
2025-12-17 main Canaccord Genuity Hold → Hold $28
2025-08-07 main Canaccord Genuity Hold → Hold $28
2025-05-15 main Canaccord Genuity Hold → Hold $29
2025-02-26 main Canaccord Genuity Hold → Hold $30
2025-02-06 reit JMP Securities Market Perform → Market Perform —
2024-10-23 main Barclays Overweight → Overweight $34
2024-10-23 main Canaccord Genuity Hold → Hold $29
2024-07-24 main Canaccord Genuity Hold → Hold $28
2023-12-06 init JMP Securities — → Market Perform —
2023-02-22 main Canaccord Genuity — → Hold $26
2021-04-28 main Canaccord Genuity — → Hold $24
2020-10-28 main Canaccord Genuity — → Hold $20
2019-12-20 init Raymond James — → Market Perform —
2018-07-11 down Barrington Research Outperform → Market Perform —
2018-06-14 down Baird Outperform → Neutral —
2017-10-25 main Baird — → Outperform $28
2017-10-25 down Needham Buy → Hold —
2017-07-26 up First Analysis Underweight → Equal-Weight —
2017-01-23 down First Analysis Equal-Weight → Underweight $18
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-01 REBROVICK LINDA E Director — 2,000 $25.00 $50,000
2026-05-28 REBROVICK LINDA E Director — 2,000 $25.00 $50,000
2026-05-28 GORDON FRANK D Director — 1,482 $24.63 $36,502
2026-05-20 O'HARA KEVIN PATRICK Officer — 3,000 $24.08 $72,230
2026-03-30 FRIST ROBERT A JR Chief Executive Officer — 4,038 — —
2026-03-30 ROBERTS SCOTT ALEXANDER Chief Financial Officer — 5,601 — —
2026-03-30 LOPRESTO JENNIFER HAYES Officer — 803 — —
2026-03-30 COLLIER MICHAEL MANNING Officer — 7,285 — —
2026-03-30 COADY TRISHA L Officer — 5,672 — —
2026-03-30 MCQUIGG MICHAEL SCOTT Officer — 5,601 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
304.06
+4.26%
291.65
+4.51%
279.06
+4.59%
266.83
Operating Revenue
304.06
+4.26%
291.65
+4.51%
279.06
+4.59%
266.83
Cost Of Revenue
107.21
+9.47%
97.94
+3.07%
95.02
+4.25%
91.14
Reconciled Cost Of Revenue
107.21
+9.47%
97.94
+3.07%
95.02
+4.25%
91.14
Gross Profit
196.85
+1.62%
193.71
+5.25%
184.04
+4.76%
175.68
Operating Expense
176.62
+2.43%
172.42
+2.62%
168.02
+2.93%
163.23
Research And Development
50.98
+4.28%
48.89
+7.36%
45.54
+2.85%
44.28
Selling General And Administration
82.16
-0.16%
82.29
+1.08%
81.41
+0.49%
81.01
Selling And Marketing Expense
49.39
+4.73%
47.16
+3.09%
45.74
+3.62%
44.15
General And Administrative Expense
32.77
-6.73%
35.13
-1.49%
35.66
-3.26%
36.87
Total Expenses
283.83
+4.98%
270.36
+2.78%
263.04
+3.41%
254.38
Operating Income
20.24
-4.94%
21.29
+32.89%
16.02
+28.68%
12.45
Total Operating Income As Reported
20.24
-4.94%
21.29
+32.89%
16.02
+28.68%
12.45
EBITDA
63.71
+1.89%
62.53
+9.52%
57.09
+13.30%
50.39
Normalized EBITDA
63.71
+1.89%
62.53
+9.52%
57.09
+13.30%
50.39
Reconciled Depreciation
43.48
+5.42%
41.24
+0.41%
41.08
+8.25%
37.95
EBIT
20.24
-4.94%
21.29
+32.89%
16.02
+28.68%
12.45
Net Income
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Pretax Income
23.22
-6.39%
24.80
+33.99%
18.51
+18.77%
15.59
Net Non Operating Interest Income Expense
3.34
-12.88%
3.83
+62.73%
2.36
+430.63%
0.44
Net Interest Income
3.34
-12.88%
3.83
+62.73%
2.36
+430.63%
0.44
Interest Income Non Operating
3.34
-12.88%
3.83
+62.73%
2.36
+430.63%
0.44
Interest Income
3.34
-12.88%
3.83
+62.73%
2.36
+430.63%
0.44
Other Income Expense
-0.36
-12.58%
-0.32
-333.82%
0.14
-94.95%
2.69
Other Non Operating Income Expenses
-0.36
-12.58%
-0.32
-333.82%
0.14
-94.95%
2.69
Tax Provision
4.88
+1.67%
4.80
+45.42%
3.30
-5.61%
3.49
Tax Rate For Calcs
0.00
+8.60%
0.00
+7.42%
0.00
-19.71%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Net Income From Continuing Operation Net Minority Interest
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Net Income From Continuing And Discontinued Operation
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Net Income Continuous Operations
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Net Income Discontinuous Operations
—
—
—
—
Normalized Income
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Net Income Common Stockholders
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Diluted EPS
0.61
-7.58%
0.66
+32.00%
0.50
+28.21%
0.39
Basic EPS
0.61
-7.58%
0.66
+32.00%
0.50
+28.21%
0.39
Basic Average Shares
30.02
-1.21%
30.39
-0.61%
30.57
-0.25%
30.65
Diluted Average Shares
30.14
-1.31%
30.54
-0.42%
30.67
-0.14%
30.72
Diluted NI Availto Com Stockholders
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Depreciation Amortization Depletion Income Statement
43.48
+5.42%
41.24
+0.41%
41.08
+8.25%
37.95
Depreciation And Amortization In Income Statement
43.48
+5.42%
41.24
+0.41%
41.08
+8.25%
37.95
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
520.37
+1.88%
510.77
+2.17%
499.94
+0.44%
497.74
Current Assets
119.66
-21.86%
153.12
+17.60%
130.21
+13.84%
114.38
Cash Cash Equivalents And Short Term Investments
57.00
-41.36%
97.22
+36.67%
71.13
+31.95%
53.91
Cash And Cash Equivalents
36.16
-39.19%
59.47
+47.45%
40.33
-12.36%
46.02
Other Short Term Investments
20.84
-44.78%
37.75
+22.56%
30.80
+290.62%
7.88
Receivables
39.00
+10.41%
35.32
-8.13%
38.45
-9.98%
42.71
Accounts Receivable
32.15
+6.51%
30.19
-12.10%
34.35
-6.49%
36.73
Gross Accounts Receivable
33.60
+6.90%
31.44
-10.50%
35.13
-5.76%
37.27
Allowance For Doubtful Accounts Receivable
-1.45
-16.35%
-1.25
-59.80%
-0.78
-43.57%
-0.54
Other Receivables
6.84
+33.35%
5.13
+25.20%
4.10
-31.44%
5.98
Prepaid Assets
16.96
-6.39%
18.12
+2.94%
17.60
+16.51%
15.11
Other Current Assets
6.70
+171.38%
2.47
-18.63%
3.03
+14.24%
2.65
Total Non Current Assets
400.72
+12.04%
357.64
-3.27%
369.73
-3.56%
383.36
Net PPE
25.93
-8.02%
28.19
-14.87%
33.12
-13.40%
38.24
Gross PPE
46.81
-1.83%
47.69
-9.38%
52.62
-10.08%
58.52
Accumulated Depreciation
-20.88
-7.13%
-19.49
+0.05%
-19.50
+3.83%
-20.28
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
4.90
+2.34%
4.79
-4.85%
5.03
+0.94%
4.98
Other Properties
27.85
-2.19%
28.48
-12.79%
32.66
-15.41%
38.60
Leases
14.06
-2.50%
14.42
-3.43%
14.94
+0.00%
14.94
Goodwill And Other Intangible Assets
328.03
+13.06%
290.14
-3.30%
300.05
-3.54%
311.07
Goodwill
217.52
+13.75%
191.22
-0.08%
191.38
-0.53%
192.40
Other Intangible Assets
110.51
+11.72%
98.92
-8.98%
108.67
-8.42%
118.67
Investments And Advances
—
—
4.13
-8.50%
4.52
Long Term Equity Investment
—
—
4.13
-8.50%
4.52
Non Current Deferred Assets
—
—
31.70
+11.84%
28.34
Non Current Deferred Taxes Assets
—
—
—
0.38
Other Non Current Assets
46.76
+18.94%
39.31
+7.53%
36.56
+2969.69%
1.19
Total Liabilities Net Minority Interest
166.35
+9.87%
151.41
-4.89%
159.19
-2.74%
163.68
Current Liabilities
124.15
+7.31%
115.69
-2.25%
118.36
+0.98%
117.21
Payables And Accrued Expenses
24.53
+11.71%
21.96
-13.02%
25.25
-33.11%
37.74
Payables
7.77
+17.21%
6.63
-11.21%
7.46
+2.44%
7.29
Accounts Payable
7.77
+17.21%
6.63
-11.21%
7.46
+2.44%
7.29
Current Accrued Expenses
16.76
+9.33%
15.33
-13.78%
17.78
-41.62%
30.46
Pensionand Other Post Retirement Benefit Plans Current
11.20
+17.80%
9.51
+0.16%
9.49
—
Current Deferred Liabilities
88.42
+4.97%
84.23
+0.72%
83.62
+5.23%
79.47
Current Deferred Revenue
88.42
+4.97%
84.23
+0.72%
83.62
+5.23%
79.47
Total Non Current Liabilities Net Minority Interest
42.20
+18.16%
35.72
-12.52%
40.83
-12.13%
46.46
Long Term Debt And Capital Lease Obligation
14.68
-15.44%
17.37
-14.23%
20.25
-13.18%
23.32
Long Term Capital Lease Obligation
14.68
-15.44%
17.37
-14.23%
20.25
-13.18%
23.32
Non Current Deferred Liabilities
19.59
+20.55%
16.25
-11.20%
18.30
-12.57%
20.93
Non Current Deferred Revenue
1.34
-18.79%
1.66
-23.70%
2.17
-26.15%
2.94
Non Current Deferred Taxes Liabilities
18.25
+25.01%
14.60
-9.52%
16.13
-10.36%
18.00
Other Non Current Liabilities
7.93
+277.49%
2.10
-7.89%
2.28
+3.21%
2.21
Stockholders Equity
354.02
-1.48%
359.36
+5.46%
340.75
+2.00%
334.06
Common Stock Equity
354.02
-1.48%
359.36
+5.46%
340.75
+2.00%
334.06
Capital Stock
231.80
-8.17%
252.43
+1.35%
249.07
-2.26%
254.83
Common Stock
231.80
-8.17%
252.43
+1.35%
249.07
-2.26%
254.83
Preferred Stock
0.00
0.00
0.00
—
Share Issued
29.58
-2.80%
30.43
+0.44%
30.30
-0.92%
30.58
Ordinary Shares Number
29.58
-2.80%
30.43
+0.44%
30.30
-0.92%
30.58
Retained Earnings
123.59
+13.41%
108.97
+17.98%
92.37
+15.15%
80.21
Gains Losses Not Affecting Retained Earnings
-1.36
+33.58%
-2.05
-196.53%
-0.69
+29.56%
-0.98
Other Equity Adjustments
-1.36
+33.58%
-2.05
-196.53%
-0.69
+29.56%
-0.98
Total Equity Gross Minority Interest
354.02
-1.48%
359.36
+5.46%
340.75
+2.00%
334.06
Total Capitalization
354.02
-1.48%
359.36
+5.46%
340.75
+2.00%
334.06
Working Capital
-4.49
-112.00%
37.43
+215.88%
11.85
+517.81%
-2.84
Invested Capital
354.02
-1.48%
359.36
+5.46%
340.75
+2.00%
334.06
Total Debt
14.68
-15.44%
17.37
-14.23%
20.25
-13.18%
23.32
Capital Lease Obligations
14.68
-15.44%
17.37
-14.23%
20.25
-13.18%
23.32
Net Tangible Assets
25.99
-62.45%
69.22
+70.07%
40.70
+76.99%
23.00
Tangible Book Value
25.99
-62.45%
69.22
+70.07%
40.70
+76.99%
23.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
63.32
+9.81%
57.66
-9.86%
63.97
+24.97%
51.19
Cash Flow From Continuing Operating Activities
63.32
+9.81%
57.66
-9.86%
63.97
+24.97%
51.19
Net Income From Continuing Operations
18.34
-8.32%
20.01
+31.51%
15.21
+25.82%
12.09
Depreciation Amortization Depletion
43.48
+5.42%
41.24
+0.41%
41.08
+8.25%
37.95
Depreciation And Amortization
43.48
+5.42%
41.24
+0.41%
41.08
+8.25%
37.95
Other Non Cash Items
11.32
+4.40%
10.84
+2.24%
10.60
+0.02%
10.60
Stock Based Compensation
8.14
+82.21%
4.47
+7.63%
4.15
+16.85%
3.55
Provisionand Write Offof Assets
1.01
-61.16%
2.60
+154.16%
1.02
+165.19%
0.39
Deferred Tax
5.12
+559.34%
-1.11
+35.42%
-1.73
-342.96%
0.71
Deferred Income Tax
5.12
+559.34%
-1.11
+35.42%
-1.73
-342.96%
0.71
Operating Gains Losses
0.19
-17.39%
0.23
-40.10%
0.38
-46.81%
0.72
Gain Loss On Investment Securities
0.19
-17.39%
0.23
-40.10%
0.38
-48.59%
0.75
Unrealized Gain Loss On Investment Securities
0.00
0.00
+100.00%
-0.42
+88.18%
-3.60
Gain Loss On Sale Of PPE
—
0.00
0.00
+100.00%
-0.03
Change In Working Capital
-24.28
-17.79%
-20.61
-225.57%
-6.33
+43.60%
-11.22
Change In Receivables
-3.98
-841.71%
0.54
-83.44%
3.24
+141.74%
-7.77
Change In Prepaid Assets
-0.96
-34.50%
-0.72
+69.84%
-2.37
-198.38%
2.41
Change In Payables And Accrued Expense
1.83
+141.56%
-4.39
-211.58%
3.94
-5.06%
4.15
Change In Accrued Expense
0.41
-36.02%
0.63
+171.36%
-0.89
-318.47%
0.41
Change In Payable
1.42
+128.27%
-5.03
-204.19%
4.83
+28.94%
3.74
Change In Account Payable
1.42
+128.27%
-5.03
-204.19%
4.83
+28.94%
3.74
Change In Other Working Capital
-1.89
-473.64%
-0.33
-109.75%
3.39
+133.12%
-10.22
Change In Other Current Assets
-19.27
-22.64%
-15.71
-8.16%
-14.52
-7082.69%
0.21
Investing Cash Flow
-50.35
-48.22%
-33.97
+39.98%
-56.60
-99.37%
-28.39
Cash Flow From Continuing Investing Activities
-50.35
-48.22%
-33.97
+39.98%
-56.60
-99.37%
-28.39
Cash From Discontinued Investing Activities
—
—
—
—
Net PPE Purchase And Sale
-3.64
-160.10%
-1.40
+36.32%
-2.20
-26.29%
-1.74
Purchase Of PPE
-3.69
-163.03%
-1.40
+36.32%
-2.20
-24.43%
-1.77
Sale Of PPE
0.04
0.00
0.00
-100.00%
0.03
Capital Expenditure
-32.16
-14.29%
-28.14
-0.49%
-28.01
-11.57%
-25.10
Capital Expenditure Reported
-28.48
-6.50%
-26.74
-3.62%
-25.81
-10.59%
-23.33
Net Investment Purchase And Sale
16.86
+418.35%
-5.30
+75.95%
-22.02
-674.74%
-2.84
Purchase Of Investment
-45.00
+39.56%
-74.45
-48.10%
-50.27
-273.27%
-13.47
Sale Of Investment
61.86
-10.55%
69.15
+144.78%
28.25
+165.88%
10.62
Net Business Purchase And Sale
-35.09
-6471.35%
-0.53
+91.88%
-6.57
-1295.75%
-0.47
Purchase Of Business
-35.09
-2601.39%
-1.30
+80.38%
-6.62
-66.99%
-3.96
Net Intangibles Purchase And Sale
—
—
-25.81
-10.59%
-23.33
Purchase Of Intangibles
—
—
-25.81
-10.59%
-23.33
Financing Cash Flow
-36.27
-703.08%
-4.52
+65.37%
-13.04
+44.99%
-23.70
Cash Flow From Continuing Financing Activities
-36.27
-703.08%
-4.52
+65.37%
-13.04
+44.99%
-23.70
Net Common Stock Issuance
-30.02
0.00
+100.00%
-8.93
+61.41%
-23.14
Common Stock Payments
-30.02
0.00
+100.00%
-8.93
+61.41%
-23.14
Common Stock Dividend Paid
-3.73
-9.58%
-3.40
-11.28%
-3.06
0.00
Cash Dividends Paid
-3.73
-9.58%
-3.40
-11.28%
-3.06
0.00
Repurchase Of Capital Stock
-30.02
0.00
+100.00%
-8.93
+61.41%
-23.14
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
-2.52
-126.06%
-1.11
-5.80%
-1.05
-86.19%
-0.56
Changes In Cash
-23.30
-221.54%
19.17
+438.31%
-5.67
-527.57%
-0.90
Effect Of Exchange Rate Changes
-0.01
+80.56%
-0.04
-56.52%
-0.02
-209.52%
0.02
Beginning Cash Position
59.47
+47.45%
40.33
-12.36%
46.02
-1.88%
46.91
End Cash Position
36.16
-39.19%
59.47
+47.45%
40.33
-12.36%
46.02
Free Cash Flow
31.16
+5.55%
29.52
-17.92%
35.96
+37.87%
26.09
Interest Paid Supplemental Data
0.10
+0.00%
0.10
-23.48%
0.13
+33.33%
0.10
Income Tax Paid Supplemental Data
—
8.70
+233.24%
2.61
+263.65%
0.72
Earnings Losses From Equity Investments
—
—
—
-2.85
Sale Of Business
0.00
-100.00%
0.77
+1527.66%
0.05
-98.65%
3.49
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category